相关实验视频

Updated: May 12, 2026

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

使用乳糖化相关基因特征预测多形质母细胞瘤的预后和治疗反应

Huan Zhu^1,2,3, Guanjun Li^2,4, Tingting Li^2,5,4

¹The First Clinical Medical College of Jinan University, Guangzhou, 510280, China.

Discover oncology

|November 26, 2025

概括

一个新的乳化五基因特征准确地预测了质母细胞瘤 (GBM) 的结果和免疫特征. 这种与乳化相关的基因特征为个性化质母细胞瘤治疗策略提供了潜力.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
免疫学免疫学免疫学

背景情况:

质母细胞瘤 (GBM) 呈现出免疫抑制性瘤微环境和代谢重编程.
不调节的乳酸代谢和乳糖化与GBM的进展有关,但它们的作用尚未完全理解.

研究的目的:

确定与GBM中乳化相关的核心基因.
开发和验证一种与乳化相关的质母细胞瘤基因预后模型.

主要方法:

对来自GBM和正常组织的基因表达数据的分析.
通过拉索回归来开发一个五基因乳化特征.
在CGGA队列中验证并比较高风险和低风险组之间的临床结果,免疫特征和治疗敏感性.
对GBM瘤微环境的单细胞测序分析.

主要成果:

识别了五个与乳化相关的枢纽基因,并构建了一个预后模型.
风险得分与免疫细胞透水平之间的相关性.
在免疫细胞亚型中观察到不同的乳化活性,特别是在与瘤相关的纤维细胞中更高.
低风险组对化疗和向疗法的敏感性增加.

结论:

开发出来的与乳化相关的基因特征是质母细胞瘤的强有力的预后生物标志物.
这种签名为GBM进展和免疫细胞动态提供了洞察力.
它为质母细胞瘤患者开发个性化治疗策略提供了潜力.

关键词:

在GBMGBMGBMGBMGBM 乳化乳化乳化预测预后预后瘤免疫微环境 (时间)

更多相关视频

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...